CONTRAINDICATIONS FOR INFLUENZA VACCINATION

1 Roberts HJ Influenza Lim WS. and pneumococcal vaccinations: an update. J R Coll Physicians Edinb 2007; 37:228–31.

2 Melegaro A Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 2004; 19:353–63.

3 Mangtani P F Cutts Hall AJ. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis 2003; 3:71–8.

4Conaty S The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. Vaccine 2004; 22(23–24):3214–24.

5 Butler JC RF Breiman Campbell JF Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270:1826–31.